New cholesterol drugs from pharma majors like Amgen, Sanofi and Regeneron Pharmaceuticals are showing promise that they can reduce cardiovascular complications.
Both Repatha, from Amgen, and Praluent, from Sanofi and Regeneron, reduced cholesterol levels by more than 60%, according to studies published Sunday in the New England Journal of Medicine. The trials also showed that patients who received the drugs had a 50% lesser risk of dying or suffering a majo...
Read more